{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:06:22Z","timestamp":1745496382160},"reference-count":61,"publisher":"American Society of Consultant Pharmacists","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2009,5,1]]},"DOI":"10.4140\/tcp.n.2009.380","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T02:14:51Z","timestamp":1294884891000},"page":"380-391","source":"Crossref","is-referenced-by-count":4,"title":["&lt;b&gt;Vaccines for Older Adults&lt;\/b&gt;"],"prefix":"10.4140","volume":"24","author":[{"given":"Sum","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz Z.","family":"Jodlowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"W Thompson","year":"2003","journal-title":"JAMA"},{"key":"2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"W Thompson","year":"2004","journal-title":"JAMA"},{"key":"3","unstructured":"3. Recommendation of the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza. MMWR 2008:57. Available at www.cdc.gov\/mmwr. Accessed August 23, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/mmwr'>www.cdc.gov\/mmwr<\/a>"},{"key":"4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2105\/AJPH.76.7.761","article-title":"Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-8","volume":"76","author":"W Barker","year":"1986","journal-title":"Am J Public Health"},{"key":"5","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"N Molinari","year":"2007","journal-title":"Vaccine"},{"key":"6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"N Cox","year":"1999","journal-title":"Lancet"},{"key":"7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/520101","article-title":"Duration of influenza A virus shedding in hospitalized patients and implications for infection control","volume":"28","author":"S Leekha","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/338870","article-title":"Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient","volume":"34","author":"G Boivin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"9","first-page":"26","article-title":"Clinical features of influenza","volume":"7","author":"K Nicholson","year":"1992","journal-title":"Semin Respir Infect"},{"key":"10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/fampra\/15.1.16","article-title":"The predictive value of influenza symptomatology in elderly people","volume":"15","author":"T Govaert","year":"1998","journal-title":"Fam Pract"},{"key":"11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1532-5415.2002.50404.x","article-title":"Clinical features of influenza A virus infection in older hospitalized persons","volume":"50","author":"E Walsh","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1086\/345668","article-title":"Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine","volume":"36","author":"K Neuzil","year":"2003","journal-title":"Clin Infect Dis"},{"key":"13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-007-6112-1","article-title":"Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital","volume":"35","author":"M Scholing","year":"2007","journal-title":"Infection"},{"key":"14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/501539","article-title":"Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients.","volume":"27","author":"H Babcock","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"15","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"T Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vaccine.2006.05.129","article-title":"Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004","volume":"25","author":"G Herrera","year":"2007","journal-title":"Vaccine"},{"key":"17","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.272.21.1661","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.","volume":"272","author":"T Govaert","year":"1994","journal-title":"JAMA"},{"key":"18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/154.2.155","article-title":"Influenza vaccine effectiveness among elderly nursing home residents: a cohort study","volume":"154","author":"A Monto","year":"2001","journal-title":"Am J Epidemiol"},{"key":"19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1532-5415.1999.tb04574.x","article-title":"Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza A (H3N2) epidemic","volume":"47","author":"S Ohmit","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"T Jefferson","year":"2005","journal-title":"Lancet"},{"key":"21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-121-12-199412150-00008","article-title":"Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization","volume":"121","author":"J Mullooly","year":"1994","journal-title":"Ann Intern Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"K Nichol","year":"2007","journal-title":"N Engl J Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","article-title":"The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.","volume":"123","author":"P Gross","year":"1995","journal-title":"Ann Intern Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/323085","article-title":"Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans","volume":"184","author":"J Nordin","year":"2001","journal-title":"J Infect Dis"},{"key":"25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/341403","article-title":"Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations","volume":"35","author":"E Hak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.158.16.1769","article-title":"Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens","volume":"158","author":"K Nichol","year":"1998","journal-title":"Arch Intern Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amepre.2006.03.008","article-title":"Influenza vaccination health impact and cost-effectiveness among adults aged 50 to 64 and 65 and older","volume":"31","author":"M Maciosek","year":"2006","journal-title":"Am J Prev Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CDLI.4.4.491-492.1997","article-title":"Time to earliest peak serum antibody response to influenza vaccine in the elderly","volume":"4","author":"P Gross","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.307.6910.988","article-title":"Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial","volume":"307","author":"T Govaert","year":"1993","journal-title":"BMJ"},{"key":"30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jama.264.9.1139","article-title":"Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial.","volume":"264","author":"K Margolis","year":"1990","journal-title":"JAMA"},{"key":"31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barre syndrome","volume":"326","author":"A Ropper","year":"1992","journal-title":"N Engl J Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia on older adults","volume":"352","author":"M Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MAJ.0b013e318156b4bc","article-title":"Immunization for the elderly","volume":"334","author":"M Bader","year":"2007","journal-title":"Am J Med Sci"},{"key":"34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"K Schmader","year":"2002","journal-title":"Clin J Pain"},{"key":"35","article-title":"Prevention of Herpes Zoster Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"57","journal-title":"MMWR"},{"key":"36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/522152","article-title":"The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine","volume":"197","author":"K Schmader","year":"2008","journal-title":"J Infect Dis"},{"key":"37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS), during a period of increasing varicella vaccine coverage, 1998-2003","volume":"5","author":"W Yih","year":"2005","journal-title":"BMC Public Health"},{"key":"38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on the herpes zoster epidemiology in the United States: a review","volume":"197","author":"M Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"M Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"40","unstructured":"40. Zostavax (Zoster vaccine live). Whitehouse Station, NJ: Merck & Co., Inc; July 2007."},{"key":"41","article-title":"Varicella-Zoster Virus.","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"R Whitley","year":"2005"},{"key":"42","unstructured":"42. Centers for Disease Control and Prevention. Herpes zoster-vaccine Q&A for providers (shingles). Available at http:\/\/www.cdc.gov\/vaccines\/ vpd-vac\/shingles\/vac-faqs-hcp.htm. Accessed April 1, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/shingles\/vac-faqs-hcp.htm'>http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/shingles\/vac-faqs-hcp.htm<\/a>"},{"key":"43","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"D Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"key":"44","unstructured":"44. Aldrich N. CDC seeks to protect older adults with shingles vaccine message. Centers for Disease Control and Prevention. Available at www. cdc.gov\/vaccines\/news\/media.htm#reporters. Accessed April 10, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/vaccines\/news\/media.htm#reporters'>www.cdc.gov\/vaccines\/news\/media.htm#reporters<\/a>"},{"key":"45","first-page":"3","article-title":"New recommendations for shingles vaccine","volume":"14","author":"M Tanzi","year":"2008","journal-title":"Pharmacy Today"},{"key":"46","unstructured":"46. Centers for Disease Control and Prevention. Pink Book Online, 10th ed. Pneumococcal disease (pages 257-270). Available at http:\/\/ www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/pneumo-508.pdf, Accessed December 12, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/pneumo-508.pdf'>http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/pneumo-508.pdf<\/a>"},{"key":"47","first-page":"1065","article-title":"Influenza and pneumococcal vaccination coverage among persons age >65\u2014United States, 2004-2005","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"48","unstructured":"48. Micromedex Healthcare Series (electronic version 5.1). Greenwood Village, CO: Thompson Micromedex; available at www.thompsonhc.com Accessed April 10, 2008. <a target=\"_blank\" href='http:\/\/www.thompsonhc.com'>www.thompsonhc.com<\/a>"},{"key":"49","article-title":"Streptococcus pneumoniae","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"D Musher","year":"2005"},{"key":"50","first-page":"1","article-title":"Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"46","year":"1997","journal-title":"MMWR"},{"key":"51","first-page":"1","article-title":"Recommended adult immunization schedule\u2014United States, October 2007-September 2008","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"52","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"L Jackson","year":"2003","journal-title":"N Engl J Med"},{"key":"53","unstructured":"53. Pneumovax 23 (Pneumococcal vaccine polyvalent). Whitehouse Station, NJ: Merck & Co., Inc; January 2008."},{"key":"54","unstructured":"54. Tetanus toxoid absorbed (Ttox) package insert. Swiftwater, PA: Aventis Pasteur, Inc; July 2005. Available at http:\/\/www.fda.gov\/ cber\/label\/ttoxave092305LB.pdf. <a target=\"_blank\" href='http:\/\/www.fda.gov\/cber\/label\/ttoxave092305LB.pdf'>http:\/\/www.fda.gov\/cber\/label\/ttoxave092305LB.pdf<\/a>"},{"key":"55","unstructured":"55. Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap; Adacel) package insert. Swiftwater, PA: Sanofi Pasteur, Inc; March 2008. Available at http:\/\/www.fda.gov\/cber\/ label\/adacelLB.pdf. <a target=\"_blank\" href='http:\/\/www.fda.gov\/cber\/label\/adacelLB.pdf'>http:\/\/www.fda.gov\/cber\/label\/adacelLB.pdf<\/a>"},{"key":"56","unstructured":"56. MMWR. Prevention of pertussis, tetanus, and diphtheria among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (ACIP Recommendations).2006;55;No RR-17. Available at http:\/\/ www.cdc.gov\/mmwr\/PDF\/rr\/rr5517.pdf. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/mmwr\/PDF\/rr\/rr5517.pdf'>http:\/\/www.cdc.gov\/mmwr\/PDF\/rr\/rr5517.pdf<\/a>"},{"key":"57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-136-9-200205070-00008","article-title":"Serologic immunity to diphtheria and tetanus in the United States","volume":"136","author":"G McQuillan","year":"2002","journal-title":"Ann Intern Med"},{"key":"58","unstructured":"58. State-specific influenza vaccination coverage among adults\u2014United States, 2006-2007 influenza season. MMWR 2008;57:1033-9. Available at http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5738a1.htm. Accessed December 12, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5738a1.htm'>http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5738a1.htm<\/a>"},{"key":"59","unstructured":"59. QuickStats: Percentage of adults aged \u226565 years who ever received a pneumococcal vaccination, by sex, age group, and race\/ethnicity-National Health Interview Survey, United States, 2007. MMWR 2008;57:723. Available at http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/ mm5726a4.htm. Accessed December 12, 2008. <a target=\"_blank\" href='http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5726a4.htm'>http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5726a4.htm<\/a>"},{"key":"60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/502317","article-title":"Improving the rates of inpatient pneumococcal vaccination: impact of standing orders versus computerized reminders to physicians","volume":"25","author":"C Coyle","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"61","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.292.19.2366","article-title":"Inpatient computer-based standing orders vs. physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial.","volume":"292","author":"P Dexter","year":"2004","journal-title":"JAMA"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T14:26:43Z","timestamp":1592231203000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2009\/00000024\/00000005\/art00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5,1]]}},"alternative-id":["788W7777842P46J4"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2009.380","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}